Clinical Trial Update: Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates TPEx chemotherapy followed by maintenance with avelumab and cetuximab as first-line treatment for recurrent or metastatic head a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: RECRUITING